> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Don’t Let Orange Book Block Competition: 23 AGs
- URL: https://www.fdaweb.com/dont-let-orange-book-block-competition-23-ags/
- Published: 2020-09-01T12:00:00.000Z
- Updated: 2026-09-14T16:27:12.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147564

Attorneys General from 23 states and territories are asking FDA to prohibit the use of the *Orange Book* to block competition. Montana attorney general **Tim Fox** [said](https://www.einpresswire.com/article%5Fprint/525297505/ag-fox-urges-continued-fda-support-for-drug-accessibility-affordability-through-its-orange-book?ref=fdaweb.com) the *Orange Book* “enables the branded drug manufacturer to obtain an automatic 30-month suspension of FDA’s approval of any potential generic competitor claiming a listed patent. This is why *Orange Book* eligibility requirements for patents are extremely important and ripe for abuse by drug delivery patents. Our coalition is concerned that expansive reading of the *Orange Book* blocks generics for insulin and other drugs that are vital to so many Americans.”

The attorneys general ask FDA to prohibit companies from listing device and component patents in the *Orange Book*.